STADA Arzneimittel AG: Supervisory Board of STADA Arzneimittel AG elects Dr. Günter von Au as new Chairman

DGAP-Ad-hoc: STADA Arzneimittel AG / Key word(s): Miscellaneous STADA Arzneimittel AG: Supervisory Board of STADA Arzneimittel AG elects Dr. Günter von Au as new Chairman 27-Sep-2017 / 16:49 CET/CEST Disclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Bad Vilbel, September 27, 2017 - At today's constituent meeting, the Supervisory Board of STADA Arzneimittel AG elected Dr. Günter von Au as its new Chairman. On September 26, 2017 the District Court of Frankfurt am Main appointed Jan-Nicolas Garbe, Benjamin Kunstler, Bruno Schick, Dr. Michael Siefke and Dr. Günter von Au as new members of the Supervisory Board with immediate effect after the former Chairman of the Supervisory Board along with four other members of the Supervisory Board had stepped down from their offices as of the end of September 25, 2017 (see the Company's ad hoc release of August 25, 2017).   Contact: STADA Arzneimittel AG / Investor Relations / Leslie Iltgen / Stadastraße 2-18 / 61118 Bad Vilbel - Germany / Tel.: [phone] / Fax: [phone] / E-mail: [e-mail] Or visit us in the Internet at www.stada.com. 27-Sep-2017 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	STADA Arzneimittel AG
	Stadastraße 2-18
	61118 Bad Vilbel
	Germany
Phone:	[phone]
Fax:	[phone]
E-mail:	[e-mail]
Internet:	www.stada.de
ISIN:	DE0007251803, DE0007251845,
WKN:	725180, 725184,
Indices:	MDAX
Listed:	Regulated Market in Dusseldorf, Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange

End of Announcement	DGAP News Service

613553  27-Sep-2017 CET/CEST